Skip to main content

Upper Limb Spasticity clinical trials at University of California Health

1 in progress, 0 open to eligible people

Showing trials for
  • Dysport® and Botox® in Adults With Upper Limb Spasticity.

    Sorry, in progress, not accepting new patients

    This study is aiming to demonstrate the non-inferiority of AbobotulinumtoxinA (aboBoNT-A) versus OnabotulinumtoxinA (onaBoNT-A) as the primary safety endpoint, and the superiority of aboBoNT-A over onaBoNT-A with respect to duration of response as the key secondary efficacy endpoint when used at optimal doses according to approved prescribing information of each product.

    at UCLA

Last updated: